MXPA03012039A - Derivados de benzo [g]quinolina para tratar glaucoma y miopia. - Google Patents

Derivados de benzo [g]quinolina para tratar glaucoma y miopia.

Info

Publication number
MXPA03012039A
MXPA03012039A MXPA03012039A MXPA03012039A MXPA03012039A MX PA03012039 A MXPA03012039 A MX PA03012039A MX PA03012039 A MXPA03012039 A MX PA03012039A MX PA03012039 A MXPA03012039 A MX PA03012039A MX PA03012039 A MXPA03012039 A MX PA03012039A
Authority
MX
Mexico
Prior art keywords
myopia
benzo
quinoline derivatives
treating glaucoma
glaucoma
Prior art date
Application number
MXPA03012039A
Other languages
English (en)
Inventor
Gull Peter
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MXPA03012039A publication Critical patent/MXPA03012039A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invencion proporciona un compuesto de la formula I, en donde A, B, X, Y y R1 son como se definen en la descripcion, y un proceso para la preparacion de los mismos. Los compuestos de la formula I son utiles como agentes farmaceuticos para el tratamiento de glaucoma y miopia.
MXPA03012039A 2001-07-09 2002-07-08 Derivados de benzo [g]quinolina para tratar glaucoma y miopia. MXPA03012039A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01116553 2001-07-09
PCT/EP2002/007594 WO2003006458A1 (en) 2001-07-09 2002-07-08 Benzo [g] quinoline derivatives for treating glaucoma and myopia

Publications (1)

Publication Number Publication Date
MXPA03012039A true MXPA03012039A (es) 2004-03-26

Family

ID=8177978

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03012039A MXPA03012039A (es) 2001-07-09 2002-07-08 Derivados de benzo [g]quinolina para tratar glaucoma y miopia.

Country Status (26)

Country Link
US (1) US7105528B2 (es)
EP (1) EP1419149B1 (es)
JP (2) JP5006505B2 (es)
KR (2) KR20100007983A (es)
CN (1) CN1293071C (es)
AR (1) AR036131A1 (es)
AT (1) ATE443060T1 (es)
AU (1) AU2002328856B2 (es)
BR (1) BR0210894A (es)
CA (1) CA2452920C (es)
DE (1) DE60233740D1 (es)
EC (1) ECSP024377A (es)
ES (1) ES2330732T3 (es)
HK (1) HK1066211A1 (es)
HU (1) HUP0400833A3 (es)
IL (2) IL159255A0 (es)
MX (1) MXPA03012039A (es)
MY (1) MY130656A (es)
NO (1) NO327549B1 (es)
NZ (1) NZ530314A (es)
PE (1) PE20030240A1 (es)
PL (1) PL208284B1 (es)
PT (1) PT1419149E (es)
RU (1) RU2300532C2 (es)
WO (1) WO2003006458A1 (es)
ZA (1) ZA200309642B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG24415A (en) * 2002-03-07 2009-05-25 Novartis Ag Quinoline derivatives
BRPI0414149A (pt) * 2003-09-05 2006-10-31 Novartis Ag composições compreendendo derivados de benzo(g)-quinolina e derivados de prostaglandina
SG11202004461YA (en) 2017-11-24 2020-06-29 H Lundbeck As New catecholamine prodrugs for use in the treatment of parkinson's disease
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262422A (en) 1991-05-02 1993-11-16 Sandoz Ltd. Octahydrobenzo[g]quinoline
DE4114325A1 (de) * 1991-05-02 1992-11-05 Sandoz Ag Octahydrobenzo(g)chinolin, seine herstellung und verwendung
GB9326010D0 (en) * 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
TW378209B (en) * 1996-07-08 2000-01-01 Novartis Ag Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them

Also Published As

Publication number Publication date
ZA200309642B (en) 2004-10-04
HUP0400833A3 (en) 2010-03-29
HUP0400833A2 (hu) 2004-07-28
IL159255A0 (en) 2004-06-01
ATE443060T1 (de) 2009-10-15
EP1419149B1 (en) 2009-09-16
NZ530314A (en) 2005-08-26
ECSP024377A (es) 2004-08-27
KR101069948B1 (ko) 2011-10-04
JP2010024243A (ja) 2010-02-04
KR20100007983A (ko) 2010-01-22
PT1419149E (pt) 2009-11-25
CA2452920A1 (en) 2003-01-23
PL208284B1 (pl) 2011-04-29
KR20040013126A (ko) 2004-02-11
BR0210894A (pt) 2004-06-22
AU2002328856B2 (en) 2005-08-04
US7105528B2 (en) 2006-09-12
WO2003006458A1 (en) 2003-01-23
AR036131A1 (es) 2004-08-11
RU2004102398A (ru) 2005-07-10
PE20030240A1 (es) 2003-04-16
JP5006505B2 (ja) 2012-08-22
US20040171628A1 (en) 2004-09-02
NO327549B1 (no) 2009-08-10
PL365254A1 (en) 2004-12-27
NO20040059L (no) 2004-01-07
CN1525969A (zh) 2004-09-01
IL159255A (en) 2010-05-17
HK1066211A1 (en) 2005-03-18
RU2300532C2 (ru) 2007-06-10
EP1419149A1 (en) 2004-05-19
DE60233740D1 (de) 2009-10-29
JP2004538278A (ja) 2004-12-24
CA2452920C (en) 2010-03-30
CN1293071C (zh) 2007-01-03
ES2330732T3 (es) 2009-12-15
MY130656A (en) 2007-07-31

Similar Documents

Publication Publication Date Title
AU2002314914A1 (en) Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
DE60000611D1 (en) 4-oxo-4,7-dihydro-thieno[2,3-b]pyridin-5-carboxamide als antivirale mittel
GEP20033140B (en) Substituted Bicyclic Derivatives Useful as Anticancer Agents
WO2001064639A3 (en) Pde iv inhibiting amides, compositions and pharmaceutical use
GEP20053476B (en) 3(5)-Amino-Pyrazole Derivatives, Process for Their Preparation and Their Use as Antitumor Agents
WO2005061501A3 (en) Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
AU2002239348A1 (en) Pyrazolopyridine derivatives
MXPA04004606A (es) Venenos de topoisomerasa solubilizados.
MXPA04006041A (es) Antivirales de piridoquinoxalina.
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
WO2003030886A3 (en) Allylamides useful in the treatment of alzheimer's disease
GEP20105095B (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
IL152337A0 (en) A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
WO2004033423A3 (en) Anticancer compounds
EP1453507A4 (en) AGENTS POISONS OF SOLUBILIZED TOPOISOMERASES
MXPA03012039A (es) Derivados de benzo [g]quinolina para tratar glaucoma y miopia.
WO2003047505A3 (en) Topoisomerase poison agents
WO2003024976A3 (en) Tricyclic indole derivatives as 5-ht ligands
WO2003004501A3 (en) (hetero) aryl substituted benzofurans as 5-ht ligands
MXPA04005151A (es) Compuestos terapeuticos.
NZ511997A (en) Isonipecotamides for the treatment of integrin-mediated disorders
MXPA03010737A (es) Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion.
CA2257646A1 (en) Benzo[g]quinoline derivatives
CA2309485A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus

Legal Events

Date Code Title Description
FG Grant or registration